Low-Density Lipoprotein Particle Number (LDL-P) Distribution in Type 2 Diabetes Who Have Achieved Low Concentrations of Non-HDL Cholesterol (non-HDL-C <80 mg/dL)

被引：0

作者：

Malave, Hector A.

Pourfarzib, Ray ^{[1
]}

Murthy, Thippeswamy H. ^{[2
]}

Burkle, Jamie ^{[3
]}

Castro, Manuel E.

机构：

[1] LipoScience, Med Affairs, Raleigh, NC USA

[2] Piedmont Heart Inst, Fayetteville, GA USA

[3] Piedmont Heart Inst, Atlanta, GA USA

来源：

CIRCULATION | 2011年 / 124卷 / 21期

关键词：

Lipoproteins;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A10067

引用

下载

页数：2

共 8 条

[1] Low-Density Lipoprotein Particle Number (LDL-P) Distribution in Type 2 Diabetes at LDL Cholesterol (LDL-C) < 50 mg/dL
Pourfarzib, Ray
Robertson, David G.
DIABETES, 2011, 60 : A191 - A191
[2] HETEROGENEITY OF LOW-DENSITY LIPOPROTEIN PARTICLE NUMBER (LDL-P) IN TYPE 2 DIABETES AT LOW CONCENTRATIONS OF LDL CHOLESTEROL (LDL-C <50 MG/DL)
Pourfarzib, Ray
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E494 - E494
[3] Evaluation of Low-Density Lipoprotein Particle Number Distribution in Patients With Type 2 Diabetes Mellitus With Low-Density Lipoprotein Cholesterol <50 mg/dl and Non-High-Density Lipoprotein Cholesterol <80 mg/dl
Malave, Hector
Castro, Manuel
Burkle, Jaime
Voros, Szilard
Dayspring, Thomas
Honigberg, Robert
Pourfarzib, Ray
AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (05): : 662 - 665
[4] Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl
Cromwell, William C.
Otvos, James D.
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (12): : 1599 - 1602
[5] Low-Density Lipoprotein Particle Number in Persons with and without Type 2 Diabetes with LDL Cholesterol <100 mg/dL and High-Sensitivity C-Reactive Protein <1 mg/L
Wright, Richard F.
Pourfarzib, Ray
Hailpern, Susan M.
DIABETES, 2010, 59 : A291 - A291
[6] Non-HDL-C/TG ratio indicates significant underestimation of calculated low-density lipoprotein cholesterol (LDL-C) better than TG level: a study on the reliability of mathematical formulas used for LDL-C estimation
Cwiklinska, Agnieszka
Wieczorek, Ewa
Gliwinska, Anna
Marcinkowska, Marta
Czaplinska, Monika
Mickiewicz, Agnieszka
Kuchta, Agnieszka
Kortas-Stempak, Barbara
Gruchala, Marcin
Debska-Slizien, Alicja
Krol, Ewa
Jankowski, Maciej
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (05) : 857 - 867
[7] Comparison of effectiveness of Rosuvastatin versus Atorvastatin on the achievement of combined c-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (<70 mg/dl) targets in patients with type 2 diabetes Mellitus (from the ANDROMEDA study)
Betteridge, D. John
Gibson, J. Martin
Sager, Philip T.
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (08): : 1245 - 1248
[8] Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/1 -: An analysis of the PROVE-IT TIMI-22 trial
Ridker, PM
Morrow, DA
Rose, LM
Rifai, N
Cannon, CP
Braunwald, E
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (10) : 1644 - 1648

← 1 →

Low-Density Lipoprotein Particle Number (LDL-P) Distribution in Type 2 Diabetes Who Have Achieved Low Concentrations of Non-HDL Cholesterol (non-HDL-C &lt;80 mg/dL)

Low-Density Lipoprotein Particle Number (LDL-P) Distribution in Type 2 Diabetes Who Have Achieved Low Concentrations of Non-HDL Cholesterol (non-HDL-C <80 mg/dL)